摘要
目的探讨子宫腺肌病对不孕症患者行体外受精．胚胎移植（IVF—ET）临床结局的影响。方法子宫内膜异位症并发不孕症患者122例，其中合并子宫腺肌病患者32例为观察组，另90例为对照组，比较两组患者促排卵反应及IVF—ET的临床结局情况。结果两组间促性腺激素用量、子宫内膜厚度、获卵数、受精数、卵裂数等差异均无统计学意义（均P〉0．05）；观察组临床妊娠率21．9％，低于对照组的30．0％，但两组间差异无统计学意义（P〉0．05）。结论子宫腺肌病对子宫内膜异位症患者IVF-ET临床结局无明显不良影响。
Objective To evaluate the influence of adenomyosis on IVF-ET outcomes in infertile patients with endometriosis. Methods 122 cases were divided into two groups：group A （ research group） contained 32 patients in infertile with both adenomyosis and endometriosis; group B （control group）contained 90 patients with endometrio- sis. The main data measured were response to COH, outcome of IVF-ET. Results Both groups had no significant difference in Gn dosage, number of oocytes obtained, number of fertilization and number of cleavage （ all P 〉 0. 05 ） , The clinical pregnancy rate of group A was 21.9%, which was lower than that of group B （30.0%）, but there were no statistical difference（P 〉 0.05）. Conclusion Adenomyosis had no adverse effects on IVF-ET outcomes in infertile women with proven endometriosis.
出处
《中国基层医药》
CAS
2010年第21期2897-2898,共2页
Chinese Journal of Primary Medicine and Pharmacy
